ArticleOncotarget2013

Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models.

Sandra Diersch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.